Title : Chronic heart failure: advances in pharmacological treatment and future perspectives.

Pub. Date : 2019 Mar 11

PMID : 30905064






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Among these, the combined angiotensin II receptor/neprilysin inhibitor (ARNI) valsartan/sacubitril has already proven highly effective in heart failure with reduced ejection fraction (HFrEF), and convincing data are available regarding the cardioprotective effects of sodium-glucose-co-transporter 2 (SGLT2) inhibitors. Valsartan membrane metalloendopeptidase Homo sapiens